| Title of Invention | A PHARMACEUTICAL COMPOSITION CONTAINING SUBSTITUTED BICYCLO [3.3.1] NONAN-2,4,9-TRIONES AS AN ACTIVE INGREDIENTS FOR PROPHYLACTIC AND/OR THERAPEUTIC TREATMENT OF NEOPLASTIC OR CANCEROUS DISEASE AND VIRAL DISEASES |
|---|---|
| Abstract | The invention relates to the use of substituted bicyclo [3.3.1] nonan-2,4,9-triones, especially clusianon and clusianon derivatives, as pharmaceutical active ingredients or medicamentous active ingredients, especially for producing medicaments for the prophylactic and/or therapeutic (curative) treatment of tumour or cancer diseases, and of viral diseases. The above-mentioned compounds can be used in cytostatic agents and antiviral agents (virostatic agents). They are especially used as inhibitors of topoisomerases and telomerases and as regulators during the MAP kinase signal transduction and can thus intervene on a cellular scale in the mechanism for multiplication of tumour or cancer cells and viruses. |
| Full Text |
|---|
337-mumnp-2004-assignment(10-11-2006).pdf
337-mumnp-2004-cancelled pages(28-10-2005).pdf
337-mumnp-2004-claims(amanded)-(28-10-2005).pdf
337-mumnp-2004-claims(complete)-(15-6-2004).pdf
337-mumnp-2004-claims(granted)-(4-3-2010).pdf
337-mumnp-2004-correspondence(4-12-2006).pdf
337-mumnp-2004-correspondence(ipo)-(5-3-2010).pdf
337-mumnp-2004-description(complete)-(15-6-2004).pdf
337-mumnp-2004-description(granted)-(4-3-2010).pdf
337-mumnp-2004-drawing(21-2-2005).pdf
337-mumnp-2004-drawing(28-10-2005).pdf
337-mumnp-2004-drawing(complete)-(15-6-2004).pdf
337-mumnp-2004-drawing(granted)-(4-3-2010).pdf
337-mumnp-2004-form 1(10-11-2006).pdf
337-mumnp-2004-form 1(28-10-2005).pdf
337-mumnp-2004-form 18(10-11-2006).pdf
337-mumnp-2004-form 19(15-6-2004).pdf
337-mumnp-2004-form 2(complete)-(15-6-2004).pdf
337-mumnp-2004-form 2(granted)-(4-3-2010).pdf
337-mumnp-2004-form 2(title page)-(complete)-(15-6-2004).pdf
337-mumnp-2004-form 2(title page)-(granted)-(4-3-2010).pdf
337-mumnp-2004-form 3(10-11-2006).pdf
337-mumnp-2004-form 3(15-6-2004).pdf
337-mumnp-2004-form 5(10-11-2006).pdf
337-mumnp-2004-form 5(15-6-2004).pdf
337-mumnp-2004-form 6(10-11-2006).pdf
337-mumnp-2004-general power of attorney(4-12-2006).pdf
337-mumnp-2004-specification(amanded)-(10-11-2006).pdf
337-mumnp-2004-wo international publication report(4-12-2006).pdf
337-mumnp-2004general power of attorney(15-3-2005).pdf
| Patent Number | 239087 | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Indian Patent Application Number | 337/MUMNP/2004 | ||||||||||||
| PG Journal Number | 11/2010 | ||||||||||||
| Publication Date | 12-Mar-2010 | ||||||||||||
| Grant Date | 04-Mar-2010 | ||||||||||||
| Date of Filing | 15-Jun-2004 | ||||||||||||
| Name of Patentee | DIAGENICS INTERNATIONAL CORPORATION | ||||||||||||
| Applicant Address | 500 W., CUMMINGS PARK, SUITE 3150, WOBURN, MA 01801 | ||||||||||||
Inventors:
|
|||||||||||||
| PCT International Classification Number | A61K31/12A61K35/64 | ||||||||||||
| PCT International Application Number | PCT/EP02/12967 | ||||||||||||
| PCT International Filing date | 2002-11-20 | ||||||||||||
PCT Conventions:
|
|||||||||||||